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In general, it is believed that the possibility of an adverse developmental outcome following conception is relatively high. In most cases, the cause of
the defect is not clear, although exposure to chemical agents at a critical period during development has been proposed to play a significant role.
Consequently, regulatory agencies such as the U.S. Environmental Protection Agency (U.S. EPA) have promulgated testing guidelines for assessing
developmental neurotoxicity of chemicals in animal testing protocols. Concerns have been expressed about the use of behavioral tests to evaluate
chemicals for developmental neurotoxicity, since some investigators believe that they lack predictive validity for human developmental neurotoxicity.
Other investigators have indicated that results from such studies are difficult to interpret because of a lack of standardization and sensitivity of the
tests. Furthermore, it has been argued that the developing organism is not especially sensitive to chemicals or, if effects are observed, the develop-
ing organism is capable of compensating for the deficit. Recent research, however, has adequately demonstrated that developing organisms are
especially vulnerable to chemical agents if the exposure occurs at a critical period during development, while other studies have supported the
assumption that functional or behavioral effects observed in animal models can be extrapolated to humans. These findings support the routine
assessment of chemicals for developmental neurotoxicity using functional end points and suggest that currently available methods could be used to
determine more precisely the mechanism of chemical-induced developmental defects. - Environ Health Perspect 103(Suppl 6):147-151 (1995)
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Developmental
Neurotoxicology: Scope
ofthe Problem
Adverse effects produced during pregnancy
and childhood, or developmental toxicity,
are an obvious societal and public health
concern. Approximately 50% of all con-
ceptions may result in spontaneous abortion
(1), while over a third ofpostimplantation
pregnancies end in embryonic or fetal loss
(2). Ofthe number oflive births, approxi-
mately 3% have one or more congenital
malformations at birth, while another 3%
have serious developmental defects by their
first birthday (3). Ofthe children in hospi-
tal wards, it has been estimated that
approximately 50% have some prenatally
acquired malformation (4).
This paper was presented at the Symposium on
Preventing Child Exposures to Environmental
Hazards: Research and Policy Issues held 18-19
March 1994 in Washington, DC. Manuscript received:
December 5, 1994; accepted: May 15, 1995.
This paper has been reviewed by the Health
Effects Research Laboratory, U.S. Environmental
Protection Agency, and approved for publication.
Mention of trade names or commercial products
does not constitute endorsement or recommenda-
tion for use.
Address correspondence to Dr. Hugh A. Tilson,
Neurotoxicology Division (MD-74B), HERL/EPA,
Research Triangle Park, NC 27711. Telephone (919)
541-2671. Fax (919) 5414849.
Developmental toxicity, which includes
death, growth retardation, and structural
or functional deficits (5), can be detected
at any time during the lifespan of the
organism as a result ofperturbations) dur-
ing gestation or after birth up to sexual
maturity. Many times, there is an associa-
tion between morphological defects or con-
genital malformations and functional
alterations. Functional deficits include
severe and mild mental retardation, cere-
bral palsy, psychoses, epilepsy and abnor-
mal neurological development, learning
and memory deficits, sensory dysfunction,
changes in motor activity, and disrupted
maturational milestones.
It has been estimated that about 20%
of developmental defects are related to
genetic causes, while another 10% appear
to be associated with known exogenous
factors such as drugs, infections, ionizing
radiation, or environmental factors (6).
Thus, about 70% ofdevelopmental defects
have no known cause. It is possible that
some of these defects may be related to
exposure to environmental agents or to a
combination ofgenetic factors, nutritional
deficiencies, drug abuse, tobacco, and/or
therapeutic agents. Generally recognized
human chemical developmental neurotoxi-
cants include drugs of abuse (ethanol,
cocaine, heroin, methadone), therapeutic
agents (diphenylhydantoin), environmen-
tal agents (methylmercury, lead, polychlo-
rinated biphenyls), and physical factors
(X-ray) (7,8).
Regulation of Developmental
Neurotoxicants
The possibility that developmental expo-
sure to environmental agents might result
in developmental neurotoxicity has led to
promulgation of regulations and testing
guidelines. Since 1975, Japan and Great
Britain have required behavioral testing in
animal studies on new drugs (9). Proposed
testing guidelines for developmental neuro-
toxic effects of drugs and other chemicals
have been published by the World Health
Organization (WHO) (10). Recently, the
U.S. Environmental Protection Agency
(U.S. EPA) published revised testing guide-
lines for developmental neurotoxicity
assessments of toxic substances and pesti-
cides (11). U.S. EPA's testing guidelines
provide direction for experimental design
and dosing as well as information concern-
ing the types ofassessments that should be
performed. Also included in U.S. EPA's
testing guidelines are measures ofmaternal
toxicity, growth and physical development
ofthe offspring, developmental landmarks,
motor activity, acoustic startle reactivity,
learning and memory, and neuropathology.
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Although testing guidelines provide direc-
tion as to the design and execution of
developmental neurotoxicity studies, they
do not specify how results should be inter-
preted or how risk is estimated. The U.S.
EPA recently published guidelines for
developmental toxicity risk assessment that
include guidance for the interpretation of
functional deficits following developmental
exposure to chemicals (12). Draft neuro-
toxicology risk assessment guidelines by the
U.S. EPA also provide direction for the
interpretation ofstructural and functional
changes following developmental exposure
to chemicals.
Critique of Developmental
Neurotoxicology
The general concern that developmental
exposure to chemicals could have adverse
effects on the structure or function ofthe
nervous system is based largely on the
assumption that the developing nervous
system is differentiallyvulnerable to pertur-
bation. In 1975, Joan Spyker wrote that "it
is now fairly well accepted that an individ-
ual is more vulnerable to certain adverse
factors during the period ofdevelopment
than at any other time in life" (13). Spyker
suggested that differences in metabolizing
enzymes, rates ofexcretion, lack ofa pro-
tective blood-brain barrier, binding of
serum and tissue proteins, and toxico-
dynamic factors could explain increased
sensitivity ofdeveloping organisms.
More recently, the possibility that the
developing organism is differentially sensi-
tive to environmental agents was under-
scored in a report by the National Research
Council (NRC) on pesticides in the diets
ofinfants and children (14). This report
repeated a fundamental maxim ofpediatric
medicine that children are not "little
adults" because they have quantitatively
different pharmaco- and toxicodynamic
capacities relative to adults. Furthermore,
the NRC report concluded that there are
both quantitative and occasionally qualita-
tive differences in the toxicities of pesti-
cides between children and adults.
Additional research to address specific dif-
ferences in neural, immune, and endocrine
system responsiveness ofadult and imma-
ture animals to several representative classes
of pesticides was recommended in the
NRC report. The NRC report also recom-
mended that the U.S. EPA continue to
revise its developmental neurotoxicity test-
ing guidelines as data are collected from
ongoing research and the pesticide registra-
tion process.
The routine assessment ofchemicals for
potential developmental neurotoxicity has,
however, been criticized on several
grounds. Dews (15), for example, sug-
gested that the assumption that the devel-
oping nervous system is generally more
sensitive than that of adults to environ-
mental factors is not true. Dews acknowl-
edged that the developing nervous system
may be quite sensitive to "a few agents,"
but the developing nervous system also is
quite adaptable to insult. Matson (16)
expresses this point by indicating that
young children have a vast capacity to
compensate for or adapt to early perturba-
tions. Furthermore, in animal studies, it is
not uncommon to find that behavioral
effects observed during early stages of
development dissipate with age. The lack
of a persistent effect following develop-
mental exposure to chemicals suggests that
no permanent adverse effect was produced
and/or that the early effects may have been
related to pharmacologic activity of the
chemical present at the time oftesting.
Another criticism ofroutine testing for
developmental neurotoxicity is that current
testing guidelines relyheavily on behavioral
assessments ofsensory, motor, and cogni-
tive function. Such tests are regarded by
some as labor intensive, expensive to per-
form, and difficult to interpret (17).
Furthermore, there is often a lack ofstan-
dardization of testing procedures across
laboratories, making comparison ofresults
difficult. Lochry (17) also indicated that
there is little evidence to suggest that
behavioral tests yield information about
developmental neurotoxicity that could not
be obtained from other end points of
developmental toxicity, including embryo/
fetal death, fetal malformation, and
delayed development. Furthermore,
Lochry suggested that behavioral effects
would probably not occur at doses that are
not also maternally toxic.
Dews (15) also expressed concern that
the predictive value of rodent screens for
developmental toxicants in humans has not
been adequately demonstrated. The NRC
report also acknowledged that extrapola-
tion oftoxicity data from adult and adoles-
cent laboratory animals to young humans
may be imprecise and careful attention to
interspecies differences is necessary (14).
Dews (15) suggested that basic research on
the mechanisms and control of develop-
ment is needed before routine testing is
required. Dews also suggested that assess-
ment ofdevelopmental toxicity should be
postponed until more is known about the
mechanism ofaction ofthe chemical under
investigation. Based on knowledge derived
from such mechanistic studies, more
appropriate and focused end points could
be selected for subsequent developmental
assessments.
To Test or Notto Test
There is concern that inappropriate toxico-
logical assessments of chemicals using
behavioral end points might unfairly
impede the development ofan otherwise
useful therapeutic, industrial, or environ-
mental agent (17). Given the expense of
such assessments and the potential loss ofa
useful product to society, such concerns
must be considered. In this section, the
points concerning the difficulties ofdevel-
opmental neurotoxicity testing raised by
Dews (15) and Lochry (17) are discussed
in greater detail. These areas ofconcern are
that a) developing organisms are not espe-
cially vulnerable, b) developing organisms
are resilient to perturbation, c) behavioral
tests provide no advantage, d) maternal
toxicity is a confounding variable, and e)
poor predictive value. The objective ofthis
discussion is to clarify important testing
and data interpretation issues and empha-
size certain concepts that underlie the
application ofbehavioral testing in devel-
opmental studies.
VulnerabilityofDevelopingOrganisms
Dews (15) asserted that it is not true that
the developing nervous system is more sen-
sitive to all aspects ofthe environment. As
stated, Dews (15) is correct, i.e., the devel-
oping nervous system is not always more
sensitive than the mature nervous system
to environmental perturbation. A case in
point is acrylamide, which produces a
peripheral neuropathy in a wide range of
species including humans (18). Edwards
(19), however, found that acrylamide given
to pregnant rats either in a single dose or in
the diet had no adverse effect on the off-
spring, even at doses that produced neu-
ropathy in the mothers. Acrylamide was
found to pass the placental barrier, suggest-
ing that the developing rat is not especially
vulnerable to the toxic effects ofacrylamide
during the early period of growth and
development. Although Agrawal and
Squibb (20) found that prenatal exposure
to acrylamide had a transient effect on the
number ofdopamine binding sites in the
striatum, unpublished behavioral studies
found no associated functional deficits in
acrylamide-exposed rats.
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The insensitivity of the developing
organism to chemicals such as acrylamide,
however, appears the exception rather than
the rule. That the developing organism is
sensitive to a wide range ofchemical agents
has been clearly documented. One of the
most comprehensive reviews of this area
can be found in a book edited by Riley and
Vorhees (7). It is clear that tests ofbehav-
ioral function are sufficient to detect effects
following developmental exposure to major
classes ofdrugs, including alcohols, anal-
gesics, stimulants, neuroleptics, antimitotics,
anxiolytics, antidepressants, barbiturates,
and drugs ofabuse; environmental chemi-
cals, including metals, pesticides, and
industrial solvents; physical factors, includ-
ing X-rays; and physiological conditions
that may result directly or indirectly from
chemical or environmental factors, includ-
ing hypoxia. There are numerous cases
where exposure to chemicals during devel-
opment have significant neurotoxicity,
whereas the same chemicals produce little
or no neurotoxicity in adults. Lead, for
example, produces significant neurotoxicity
ifexposure occurs during development but
little ifanyeffect in adults (7).
Although the literature supports the
conclusion that the developing organism is
not always more sensitive to environmental
factors than adults, there is clear evidence
that the developing organism is differen-
tially sensitive to environmental factors rel-
ative to the adult. One reason for this
differential sensitivity is that the develop-
ing nervous system undergoes defined peri-
ods of neurogenesis and migration,
synaptogenesis, gliogenesis, and myelina-
tion, events that have reached a relative
steady-state in the adult organism. Rodier
(21,22) was among the first to indicate
that there are specific times during matura-
tion of the central nervous system when
chemical-induced perturbation can cause
neurotoxicity. Exposure to a chemical dur-
ing a critical period ofdevelopment will
produce neurotoxicity, while exposure to
the same agent at another less critical
period ofdevelopment will have little or no
effect. A recent example of this principle
can be found in a paper by Balduini and
colleagues (23), who exposed rats to
methylazomethanol (MAM) at different
times during gestation. In this study, preg-
nant rats were injected with MAM on ges-
tational days 14, 15, 16, 17, 18, or 19 and
the offspring tested behaviorally at various
ages. These investigators found that gesta-
tional exposure to MAM caused selective
deficits in learning and motor activity that
were dependent on the time ofadministra-
tion. If MAM was given on day 18 or 19
of gestation, learning deficits were
observed; injection ofMAM on any other
day gestationally had no significant effect
on learning. With regard to motor activity,
the presence and direction of effect
(increased or decreased activity) was depen-
dent on the day of gestational exposure.
Adults exposed to single doses ofMAM do
not display persistent behavioral effects.
The study by Balduini et al. (23) indicates
that effects following developmental expo-
sures cannot with any degree ofcertainty
be predicted from experiments done with
adults and that the presence ofa neurotoxi-
cological effect can depend on the day that
exposure occurs. Testing guidelines for
developmental neurotoxicity (11) provide
for both pre- and postnatal exposure to
ensure that a critical period ofdevelopment
is not missed.
ResilienceofDeveloping Organisms
The second issue, raised by Dews (15) and
Matson (16), concerned the resiliency of
the developing organism to environmental
insult. It is sometimes observed in develop-
mental neurotoxicological studies that
effects observed at an early age can dissi-
pate with age, suggesting that no long-
term, persistent effect has been produced.
It has been observed, however, that in cases
where recovery of function appears to
occur with age, there is still some evidence
ofa residual deficit that can be determined
with subsequent testing or following phar-
macological challenge. Harry and Tilson
(24) dosed rats with triethyl tin (TET) on
day 5 postpartum and assessed develop-
mental neurotoxicity using behavioral tests
for up to 90 days ofage. Rats exposed to
TET were hyperactive at 21, 28, and 60
days of age. However, TET-exposed ani-
mals tended to be hypoactive relative to
controls at 90 days ofage. One interpreta-
tion ofthese data is that the motor deficit
seen at earlier ages was not permanent and
that adult animals exposed developmen-
tally to TET had recovered. In a subse-
quent experiment, however, Harry and
Tilson (25) challenged adult rats exposed
to TET developmentally with apomor-
phine, a chemical that stimulates motor
activity by activating dopamine receptors
directly, and found that TET-exposed ani-
mals were significantly more sensitive to
the stimulant effects ofapomorphine than
controls. Subsequent neurochemical
experiments found a persistent change in
dopamine binding in the striatum of
TET-exposed animals. These studies indi-
cate that apparent recovery offunction that
occurs with age should be interpreted cau-
tiously in developmental studies. Long-
term, persistent deficits in nervous system
function cannot be ruled out in studies
where apparent recovery is observed.
Another point that should be consid-
ered is that developmental exposure to
neurotoxicants might interact with the
aging process. Barone and colleagues (26)
exposed rats to triethyl tin and found that
the effects on learning in younger animals
were exacerbated as the animals aged. In
this study, rats dosed with triethyl tin
showed marginal deficits at 3 months of
age, no deficits at 12 months ofage, and
significant cognitive impairment relative to
age-matched controls at 24 months ofage.
Delayed onset neurotoxicity has also been
reported in monkeys exposed developmen-
tally to methylmercury (27).
Advantage ofTraditional
BehavioralTests
Lochry (17) argued that the behavioral
measures used in developmental neurotoxi-
city studies are not more sensitive than
other, more traditional indicators oftoxic-
ity. Faber and O'Donoghue (28), for
example, identified 41 developmental neu-
rotoxicants from Shepard's catalogue of
teratogenic agents (4) and found that 37
showed positive effects in the Chernoff/
Kavlock assay, which measures the number
ofpups per litter, the birthweight, and via-
bility ofpups up to 3 or 4 days postnatally.
These findings suggested that the
Chernoff/Kavlock assay may be sufficient
to detect potential developmental neuro-
toxicants and that more costly behavioral
tests may not be necessary for screening. In
a followup to the Faber and O'Donoghue
report, Goldey et al. (29) evaluated studies
in which 126 compounds were assessed for
developmental neurotoxicity. Studies in
which all or part ofthe Chernoff/Kavlock
screen had been used and behavioral test-
ing had been performed on the same com-
pound were selected for further analysis.
Goldey et al. (29) found that of the 126
agents evaluated, 110 were found to be
developmental neurotoxicants using behav-
ioral tests. Of those 110 compounds, 72
had been tested on one ofthe measures in
the Chernoff/Kavlock assay; more than a
third ofthem had been found to be nega-
tive. The developmental neurotoxicants
that were negative in the Chernoff/Kavlock
assay included several drugs, food addi-
tives, and solvents. These observations
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indicate that behavioral tests afford a level
ofsensitivity needed in developmental neu-
rotoxicology studies.
Lochry (17) also suggested that the
interpretation ofbehavioral results may be
problematic in studies involving the pres-
ence ofmaternal toxicity. Adverse develop-
mental neurotoxic effects can often result
at doses that cause minimal maternal toxic-
ity (e.g., < 20% reduction in weight gain
during gestation and lactation), and such
effects should not be discounted as sec-
ondary to maternal toxicity. Effects seen at
doses causing excessive maternal toxicity
(>20% reduction in weight gain) are prob-
lematic and are difficult to interpret. At
present, it cannot be assumed that develop-
mental effects observed at doses that cause
minimal maternal toxicity result only from
maternal toxicity. Instead, it may be that
the mother and developing organism are
equally sensitive to that dose. Furthermore,
whether or not developmental neurotoxic
effects are secondary to maternal toxicity,
the maternal effects may be reversible,
while effects on the offspring may be per-
sistent.
PredictiveValueof
AnimalBehavioralTests
One major concern about the use of
behavioral tests in animal studies is that
they may have little relationship to what is
measured in humans. This issue was
specifically addressed in a workshop on the
qualitative and quantitative comparability
ofhuman and animal developmental neu-
rotoxicity (30). One ofthe working groups
at that meeting assessed the comparability
of measures ofdevelopmental neurotoxic-
ity produced by several known human
developmental neurotoxicants (31). The
working group identified at least four crite-
ria for animal models of human develop-
mental neurotoxicity including a) the
developmental profile of the behavior or
function in animals should resemble that
observed in humans, b) the neural sub-
strate underlying the function in animals
should resemble that found in humans,
c) there should be operational similarities
in the assessment of the function in ani-
mals and humans, and d) treatments that
affect function in animals should affect
similar functions in humans. Based on
these criteria, the working group identified
five functional domains that serve as the
basis for comparability ofeffects between
humans and animals, including sensory,
motivational/ arousal, cognitive, motor,
and social functions.
The effects ofseveral known develop-
mental neurotoxicants in humans and ani-
mals were then compared based on a
review of the existing literature. A good
degree of qualitative correspondence was
found in humans and animals for the
developmental neurotoxicity of methyl-
mercury, anticonvulsants such as pheny-
toin, lead, ethanol, polychlorinated
biphenyls, and ionizing radiation. The
working group also observed that the
degree ofquantitative comparability, how-
ever, was not as good, possibly because of
limited dose-response comparisons,
incomplete or missing information con-
cerning the actual internal dose relative to
the administered dose, and insufficient
information concerning the most sensitive
end points. One conclusion from develop-
mental neurotoxicity studies using animal
models is that the degree of cross-species
comparability is facilitated by close atten-
tion to using end points for which there
are comparable developmental profiles and
common underlying neural substrates.
Good quantitative comparisons between
animal models and humans will be im-
proved following development of mathe-
matical and physiologically based
dose-response models.
Summary and Conclusions
The area ofdevelopmental neurotoxicology
has evolved rapidly over the last several
years. Initially it was shown that develop-
mental exposure to environmental agents
can affect behavioral measures in the off-
spring. Subsequent experiments have
confirmed that the developing organism is
sensitive to a wide range ofchemical fac-
tors. The potential threat ofdevelopmental
neurotoxicity following exposure to chemi-
cals has led to the promulgation of regula-
tory guidelines for the preapproval of
chemicals. The potential expense of such
tests, however, has elicited concerns about
the general sensitivity of the developing
organism, sensitivity of functional tests,
and interpretation of data generated in
behavioral developmental studies.
Research, however, has shown that the
developing organism can be highly sensi-
tive to a wide range ofenvironmental fac-
tors if exposure occurs at a critical period
of nervous system development. Further-
more, standardized behavioral tests are now
available to assess the developmental neu-
rotoxicity ofchemicals and such tests have
been successful in detecting and quantify-
ing the effects of human developmental
neurotoxicants in animal models.
Concerns about the cost effectiveness of
developmental neurotoxicity studies have
been raised in recent years. Advances in
developmental neurobiology and experience
with standardized testing protocols in neu-
rotoxicology, however, suggest that well-
designed studies selecting appropriate
behavioral tests can provide useful informa-
tion about potential neurotoxicity ofchemi-
cal agents. In addition, behavioral measures
in conjunction with appropriate neuro-
chemical and anatomical end points can be
used to address hypothesis-driven questions
concerning the site and mechanism of
action ofdevelopmental neurotoxicants.
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